Wealth Enhancement Advisory Services
TNYA icon

Wealth Enhancement Advisory Services’s Tenaya Therapeutics TNYA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.3K Buy
+76,183
New +$57.8K ﹤0.01% 3874
2025
Q3 		– Sell
-38,722
Closed -$23.7K – 3704
2025
Q2 		$23.7K Sell
38,722
-19,825
-34% -$10.1K ﹤0.01% 3287
2025
Q1 		$33.4K Buy
+58,547
New +$57.8K ﹤0.01% 2876

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Enhancement Advisory Services's TNYA Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 76,183 shares worth $66.3K. The stake represents ﹤0.01% of the portfolio and ranks #3874 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in TNYA as recently as Q2 2025.

Wealth Enhancement Advisory Services first reported a position in TNYA in Q1 2025 and has held it in 3 quarters since. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Wealth Enhancement Advisory Services held 76,183 shares of Tenaya Therapeutics worth $66.3K as of Q2 2026.
  • Tenaya Therapeutics was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3874 holding.
  • Wealth Enhancement Advisory Services first reported a position in Tenaya Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.